Project Results for Biomonitoring Exposures Study (BEST) - 2.Expanded
Project: Biomonitoring Exposures Study (BEST) - 2.Expanded
- Study Group: 341 adults
- Sample Collection Date:
Chemical Group: Environmental Phenols
- Measured in: Urine
Weighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||||
| Benzophenone-3 | Benzophenone-3 | NA | µg/L | 218 | 76.7 | 43.4 | 135 | 10.9 | 76.2 | 431 | 6720 | 95.8% | 1.00 µg/L | ● |
| Benzophenone-3 | Benzophenone-3 | Creatinine | µg/g creatinine | 218 | 83.8 | 49.1 | 143 | 11.8 | 70.8 | 408 | 3520 | 95.8% | 1.00 µg/L | ● |
| BPA | Bisphenol A | NA | µg/L | 218 | 1.33 | 1.05 | 1.69 | 0.648 | 1.52 | 3.56 | 5.66 | 97.4% | 0.100 µg/L | ● |
| BPA | Bisphenol A | Creatinine | µg/g creatinine | 218 | 1.46 | 1.20 | 1.77 | 0.786 | 1.53 | 2.39 | 5.58 | 97.4% | 0.100 µg/L | ● |
| Butyl paraben | Butyl paraben | NA | µg/L | 218 | * | * | * | <LOD | <LOD | 0.456 | 20.5 | 33.4% | 0.200 µg/L | ● |
| Butyl paraben | Butyl paraben | Creatinine | µg/g creatinine | 218 | * | * | * | <LOD | <LOD | 0.834 | 21.2 | 33.4% | 0.200 µg/L | ● |
| Ethyl paraben | Ethyl paraben | NA | µg/L | 218 | * | * | * | <LOD | <LOD | 10.0 | 168 | 47.8% | 1.00 µg/L | ● |
| Ethyl paraben | Ethyl paraben | Creatinine | µg/g creatinine | 218 | * | * | * | <LOD | <LOD | 11.7 | 161 | 47.8% | 1.00 µg/L | ● |
| Methyl paraben | Methyl paraben | NA | µg/L | 218 | 62.9 | 41.3 | 95.9 | 21.1 | 75.4 | 241 | 906 | 94.3% | 1.00 µg/L | ● |
| Methyl paraben | Methyl paraben | Creatinine | µg/g creatinine | 218 | 68.8 | 47.6 | 99.6 | 23.5 | 83.8 | 237 | 924 | 94.3% | 1.00 µg/L | ● |
| Propyl paraben | Propyl paraben | NA | µg/L | 218 | 9.58 | 5.98 | 15.4 | <LOD | 9.05 | 55.5 | 325 | 71.5% | 1.00 µg/L | ● |
| Propyl paraben | Propyl paraben | Creatinine | µg/g creatinine | 218 | 10.48 | 6.68 | 16.4 | <LOD | 9.51 | 70.2 | 287 | 71.5% | 1.00 µg/L | ● |
| Triclosan | Triclosan | NA | µg/L | 218 | 11.9 | 7.34 | 19.4 | 2.25 | 9.09 | 60.4 | 801 | 98.5% | 0.100 µg/L | ● |
| Triclosan | Triclosan | Creatinine | µg/g creatinine | 218 | 13.1 | 8.00 | 21.3 | 2.31 | 11.3 | 54.2 | 812 | 98.5% | 0.100 µg/L | ● |
Footnotes
- ●Expanded BEST data from 218 participants was weighted, a statistical method to adjust over-represented and under-represented samples, so that the summary results adequately reflect the population of California’s Central Valley. Unweighted results are available to download on the Biomonitoring Exposures Study (BEST) – 2. Expanded project page.
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
Chemical Group: Herbicides
- Measured in: Urine
Weighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||||
| 2,4-D | 2,4-D | NA | µg/L | 218 | 0.173 | 0.137 | 0.217 | 0.0807 | 0.159 | 0.302 | 1.29 | 81.9% | 0.0500 µg/L | ● |
| 2,4-D | 2,4-D | Creatinine | µg/g creatinine | 218 | 0.189 | 0.153 | 0.233 | 0.113 | 0.185 | 0.323 | 1.61 | 81.9% | 0.0500 µg/L | ● |
Footnotes
- ●Expanded BEST data from 218 participants was weighted, a statistical method to adjust over-represented and under-represented samples, so that the summary results adequately reflect the population of California’s Central Valley. Unweighted results are available to download on the Biomonitoring Exposures Study (BEST) – 2. Expanded project page.
Chemical Group: Metals
- Measured in: Blood
Weighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||||
| Cadmium | Cadmium | NA | µg/L | 315 | 0.247 | 0.220 | 0.277 | 0.161 | 0.227 | 0.380 | 0.939 | 100% | 0.0111 µg/L | □ |
| Lead | Lead | NA | µg/dL | 315 | 0.749 | 0.664 | 0.846 | 0.416 | 0.703 | 1.31 | 2.43 | 100% | 0.0109 µg/dL | □ |
| Manganese | Manganese | NA | µg/L | 315 | 9.17 | 8.76 | 9.60 | 7.63 | 9.08 | 10.8 | 15.7 | 100% | 1.00 µg/L | □ |
| Mercury | Mercury | NA | µg/L | 315 | 0.677 | 0.573 | 0.799 | 0.339 | 0.693 | 1.26 | 3.52 | 99.9% | 0.0294 µg/L | □ |
Footnotes
- □Expanded BEST data from 315 participants was weighted, a statistical method to adjust over-represented and under-represented samples, so that the summary results adequately reflect the population of California’s Central Valley. Unweighted results are available to download on the Biomonitoring Exposures Study (BEST) – 2. Expanded project page.
Chemical Group: Metals
- Measured in: Urine
Weighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||||
| Arsenic | Arsenic | NA | µg/L | 218 | 8.60 | 7.05 | 10.5 | 5.08 | 10.3 | 14.0 | 41.6 | 100% | 0.0493 µg/L | ● |
| Arsenic | Arsenic | Creatinine | µg/g creatinine | 218 | 9.40 | 8.25 | 10.71 | 5.35 | 9.29 | 13.8 | 29 | 100% | 0.0493 µg/L | ● |
| Cadmium | Cadmium | NA | µg/L | 218 | 0.184 | 0.145 | 0.235 | 0.0932 | 0.173 | 0.412 | 1.02 | 87.8% | 0.0420 µg/L | ● |
| Cadmium | Cadmium | Creatinine | µg/g creatinine | 218 | 0.202 | 0.166 | 0.245 | 0.111 | 0.193 | 0.334 | 0.928 | 87.8% | 0.0420 µg/L | ● |
| Cobalt | Cobalt | NA | µg/L | 218 | 0.190 | 0.146 | 0.247 | 0.0872 | 0.181 | 0.417 | 1.24 | 98.5% | 0.0113 µg/L | ● |
| Cobalt | Cobalt | Creatinine | µg/g creatinine | 218 | 0.207 | 0.168 | 0.256 | 0.113 | 0.166 | 0.305 | 1.36 | 98.5% | 0.0113 µg/L | ● |
| Manganese | Manganese | NA | µg/L | 218 | * | * | * | <LOD | 0.0555 | 0.106 | 0.461 | 56.3% | 0.0449 µg/L | ● |
| Manganese | Manganese | Creatinine | µg/g creatinine | 218 | * | * | * | <LOD | 0.0632 | 0.123 | 0.89 | 56.3% | 0.0449 µg/L | ● |
| Mercury | Mercury | NA | µg/L | 218 | 0.148 | 0.114 | 0.194 | 0.0766 | 0.154 | 0.358 | 1.09 | 93.9% | 0.0163 µg/L | ● |
| Mercury | Mercury | Creatinine | µg/g creatinine | 218 | 0.162 | 0.130 | 0.202 | 0.0756 | 0.182 | 0.314 | 0.811 | 93.9% | 0.0163 µg/L | ● |
| Molybdenum | Molybdenum | NA | µg/L | 218 | 40.4 | 31.8 | 51.4 | 20.0 | 48.6 | 81.1 | 202 | 100% | 0.0736 µg/L | ● |
| Molybdenum | Molybdenum | Creatinine | µg/g creatinine | 218 | 44.2 | 36.9 | 52.9 | 28.8 | 40.2 | 71.0 | 158 | 100% | 0.0736 µg/L | ● |
| Thallium | Thallium | NA | µg/L | 218 | 0.164 | 0.136 | 0.197 | 0.125 | 0.182 | 0.296 | 0.373 | 98.4% | 0.00982 µg/L | ● |
| Thallium | Thallium | Creatinine | µg/g creatinine | 218 | 0.179 | 0.161 | 0.198 | 0.135 | 0.180 | 0.247 | 0.392 | 98.4% | 0.00982 µg/L | ● |
| Tungsten | Tungsten | NA | µg/L | 218 | 0.0762 | 0.0584 | 0.0994 | 0.0447 | 0.0924 | 0.155 | 0.333 | 95.8% | 0.00493 µg/L | ● |
| Tungsten | Tungsten | Creatinine | µg/g creatinine | 218 | 0.0833 | 0.0684 | 0.101 | 0.0475 | 0.0812 | 0.141 | 0.399 | 95.8% | 0.00493 µg/L | ● |
| Uranium | Uranium | NA | µg/L | 218 | 0.00709 | 0.00533 | 0.00944 | 0.00215 | 0.00752 | 0.0181 | 0.0635 | 82.0% | 0.00134 µg/L | ● |
| Uranium | Uranium | Creatinine | µg/g creatinine | 218 | 0.00775 | 0.00606 | 0.00990 | 0.00349 | 0.00664 | 0.0149 | 0.0645 | 82.0% | 0.00134 µg/L | ● |
Footnotes
- ●Expanded BEST data from 218 participants was weighted, a statistical method to adjust over-represented and under-represented samples, so that the summary results adequately reflect the population of California’s Central Valley. Unweighted results are available to download on the Biomonitoring Exposures Study (BEST) – 2. Expanded project page.
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
Chemical Group: Organochlorine Pesticides
- Measured in: Serum
Weighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||||
| beta-Hexachlorocyclohexane (beta-HCH) | b-HCH | Lipids | ng/g lipid | 217 | * | * | * | <LOD | <LOD | 5.22 | 24.7 | 35.5% | 0.00800 ng/mL | ♦ |
| DDE (para,para) | para,para-DDT and/or para,para-DDE | Lipids | ng/g lipid | 217 | 217 | 176 | 267 | 110 | 174 | 542 | 1240 | 100% | 0.0160 ng/mL | ♦ |
| DDT (ortho,para) | ortho,para-DDT | Lipids | ng/g lipid | 217 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.5% | 0.00800 ng/mL | ♦ |
| DDT (para,para) | para,para-DDT | Lipids | ng/g lipid | 217 | * | * | * | <LOD | 1.71 | 2.58 | 4.98 | 64.2% | 0.00800 ng/mL | ♦ |
| Hexachlorobenzene (HCB) | HCB | Lipids | ng/g lipid | 217 | 8.82 | 8.21 | 9.47 | 7.27 | 8.71 | 11.1 | 16.1 | 100% | 0.0106 ng/mL | ♦ |
| Oxychlordane | Chlordane | Lipids | ng/g lipid | 217 | 3.73 | 3.09 | 4.50 | 2.00 | 3.54 | 7.37 | 15.0 | 83.4% | 0.00800 ng/mL | ♦ |
| trans-Nonachlor | Chlordane | Lipids | ng/g lipid | 217 | 6.92 | 5.68 | 8.44 | 3.69 | 6.43 | 14.9 | 34.4 | 89.9% | 0.00800 ng/mL | ♦ |
Footnotes
- ♦Expanded BEST data from 217 participants was weighted, a statistical method to adjust over-represented and under-represented samples, so that the summary results adequately reflect the population of California’s Central Valley. Unweighted results are available to download on the Biomonitoring Exposures Study (BEST) – 2. Expanded project page.
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
Chemical Group: Organophosphate Pesticides
- Measured in: Urine
Weighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||||
| IMPY | Diazanon | NA | µg/L | 218 | * | * | * | <LOD | <LOD | 0.199 | 0.849 | 47.5% | 0.0500 µg/L | ● |
| IMPY | Diazanon | Creatinine | µg/g creatinine | 218 | * | * | * | <LOD | <LOD | 0.216 | 0.829 | 47.5% | 0.0500 µg/L | ● |
| TCPy | Chlorpyrifos (Chlorpyrifos methyl) | NA | µg/L | 218 | 0.912 | 0.792 | 1.05 | <LOD | 0.991 | 1.39 | 2.72 | 74.6% | 0.500 µg/L | ● |
| TCPy | Chlorpyrifos (Chlorpyrifos methyl) | Creatinine | µg/g creatinine | 218 | 0.997 | 0.883 | 1.13 | <LOD | 0.953 | 1.40 | 2.61 | 74.6% | 0.500 µg/L | ● |
Footnotes
- ●Expanded BEST data from 218 participants was weighted, a statistical method to adjust over-represented and under-represented samples, so that the summary results adequately reflect the population of California’s Central Valley. Unweighted results are available to download on the Biomonitoring Exposures Study (BEST) – 2. Expanded project page.
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
Chemical Group: Other Pesticides
- Measured in: Urine
Weighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||||
| DEET | DEET | NA | µg/L | 218 | * | * | * | <LOD | <LOD | 0.102 | 0.286 | 38.5% | 0.0500 µg/L | ● |
| DEET | DEET | Creatinine | µg/g creatinine | 218 | * | * | * | <LOD | <LOD | 0.117 | 0.425 | 38.5% | 0.0500 µg/L | ● |
Footnotes
- ●Expanded BEST data from 218 participants was weighted, a statistical method to adjust over-represented and under-represented samples, so that the summary results adequately reflect the population of California’s Central Valley. Unweighted results are available to download on the Biomonitoring Exposures Study (BEST) – 2. Expanded project page.
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
Chemical Group: Perchlorate
- Measured in: Urine
Weighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||||
| Perchlorate | NA | µg/L | 218 | 2.91 | 2.38 | 3.56 | 2.00 | 2.98 | 4.59 | 18.6 | 100% | 0.0100 µg/L | ● | |
| Perchlorate | Creatinine | µg/g creatinine | 218 | 3.19 | 2.68 | 3.79 | 1.79 | 2.87 | 5.47 | 13.9 | 100% | 0.0100 µg/L | ● | |
Footnotes
- ●Expanded BEST data from 218 participants was weighted, a statistical method to adjust over-represented and under-represented samples, so that the summary results adequately reflect the population of California’s Central Valley. Unweighted results are available to download on the Biomonitoring Exposures Study (BEST) – 2. Expanded project page.
Chemical Group: Perfluoroalkyl and Polyfluoroalkyl Substances (PFASs)
- Measured in: Serum
Weighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||||
| Et-PFOSA-AcOH | Et-PFOSA-AcOH | NA | ng/mL | 337 | * | * | * | <LOD | 0.00732 | 0.0218 | 0.0865 | 51.7% | 0.00682 ng/mL | ○ |
| Me-PFOSA-AcOH | Me-PFOSA-AcOH | NA | ng/mL | 337 | 0.120 | 0.106 | 0.136 | 0.0686 | 0.124 | 0.202 | 0.514 | 98.4% | 0.0114 ng/mL | ○ |
| PFDA | PFDA | NA | ng/mL | 337 | 0.162 | 0.146 | 0.180 | 0.0901 | 0.161 | 0.262 | 0.522 | 79.1% | 0.0877 ng/mL | ○ |
| PFDoA | PFDoA | NA | ng/mL | 337 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.4% | 0.148 ng/mL | ○ |
| PFHpA | PFHpA | NA | ng/mL | 337 | * | * | * | <LOD | 0.0189 | 0.0480 | 0.135 | 61.4% | 0.0121 ng/mL | ○ |
| PFHxS | PFHxS | NA | ng/mL | 337 | 1.09 | 0.952 | 1.26 | 0.606 | 1.13 | 1.85 | 4.59 | 99.5% | 0.0538 ng/mL | ○ |
| PFNA | PFNA | NA | ng/mL | 337 | 0.739 | 0.660 | 0.827 | 0.497 | 0.764 | 1.18 | 1.95 | 99.5% | 0.0282 ng/mL | ○ |
| PFOA | PFOA | NA | ng/mL | 337 | 1.42 | 1.26 | 1.60 | 1.04 | 1.63 | 2.34 | 4.07 | 99.5% | 0.0426 ng/mL | ○ |
| PFOS | PFOS | NA | ng/mL | 337 | 5.07 | 4.53 | 5.68 | 3.41 | 5.05 | 7.82 | 17.6 | 99.7% | 0.0943 ng/mL | ○ |
| PFOSA | PFOSA | NA | ng/mL | 337 | * | * | * | <LOD | <LOD | 0.0246 | 0.108 | 29.2% | 0.0212 ng/mL | ○ |
| PFUnDA | PFUnDA | NA | ng/mL | 337 | 0.0841 | 0.0743 | 0.0952 | 0.0447 | 0.0820 | 0.138 | 0.363 | 80.3% | 0.0371 ng/mL | ○ |
Footnotes
- ○Expanded BEST data from 337 participants was weighted, a statistical method to adjust over-represented and under-represented samples, so that the summary results adequately reflect the population of California’s Central Valley. Unweighted results are available to download on the Biomonitoring Exposures Study (BEST) – 2. Expanded project page.
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
Chemical Group: Phthalates
- Measured in: Urine
Weighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||||
| MBzP | Benzylbutyl phthalate (BzBP) | NA | µg/L | 218 | 5.20 | 4.09 | 6.61 | 2.82 | 5.57 | 9.44 | 25.6 | 100% | 0.200 µg/L | ● |
| MBzP | Benzylbutyl phthalate (BzBP) | Creatinine | µg/g creatinine | 218 | 5.69 | 4.81 | 6.72 | 3.36 | 5.86 | 9.05 | 22.3 | 100% | 0.200 µg/L | ● |
| MCHP | Dicyclohexyl phthalate (DCHP) | NA | µg/L | 218 | * | * | * | <LOD | <LOD | <LOD | <LOD | <0.1% | 0.100 µg/L | ● |
| MCHP | Dicyclohexyl phthalate (DCHP) | Creatinine | µg/g creatinine | 218 | * | * | * | <LOD | <LOD | <LOD | <LOD | <0.1% | 0.100 µg/L | ● |
| MCPP | Di-n-octyl phthalate (DnOP) | NA | µg/L | 218 | 2.01 | 1.57 | 2.58 | 0.943 | 2.30 | 4.40 | 16.0 | >99.9% | 0.100 µg/L | ● |
| MCPP | Di-n-octyl phthalate (DnOP) | Creatinine | µg/g creatinine | 218 | 2.20 | 1.79 | 2.71 | 1.17 | 1.87 | 3.54 | 15.2 | >99.9% | 0.100 µg/L | ● |
| MECPP | Di-2-ethylhexyl phthalate (DEHP) | NA | µg/L | 218 | 9.62 | 7.62 | 12.1 | 5.35 | 11.0 | 20.5 | 47.9 | 100% | 0.190 µg/L | ● |
| MECPP | Di-2-ethylhexyl phthalate (DEHP) | Creatinine | µg/g creatinine | 218 | 10.52 | 9.01 | 12.3 | 6.81 | 10.5 | 16.9 | 36.1 | 100% | 0.190 µg/L | ● |
| MEHHP | Di-2-ethylhexyl phthalate (DEHP) | NA | µg/L | 218 | 6.05 | 4.67 | 7.83 | 2.70 | 7.17 | 12.7 | 31.9 | >99.9% | 0.190 µg/L | ● |
| MEHHP | Di-2-ethylhexyl phthalate (DEHP) | Creatinine | µg/g creatinine | 218 | 6.61 | 5.50 | 7.94 | 4.33 | 6.75 | 10.4 | 19.6 | >99.9% | 0.190 µg/L | ● |
| MEHP | Di-2-ethylhexyl phthalate (DEHP) | NA | µg/L | 218 | 1.89 | 1.38 | 2.59 | 0.857 | 2.28 | 5.21 | 13.3 | 89.9% | 0.190 µg/L | ● |
| MEHP | Di-2-ethylhexyl phthalate (DEHP) | Creatinine | µg/g creatinine | 218 | 2.07 | 1.63 | 2.62 | 0.936 | 2.16 | 4.24 | 12.9 | 89.9% | 0.190 µg/L | ● |
| MEOHP | Di-2-ethylhexyl phthalate (DEHP) | NA | µg/L | 218 | 4.49 | 3.43 | 5.87 | 2.37 | 4.87 | 8.27 | 35.0 | >99.9% | 0.100 µg/L | ● |
| MEOHP | Di-2-ethylhexyl phthalate (DEHP) | Creatinine | µg/g creatinine | 218 | 4.91 | 4.02 | 6.00 | 3.00 | 4.96 | 7.06 | 21.5 | >99.9% | 0.100 µg/L | ● |
| MEP | Diethyl phthalate (DEP) | NA | µg/L | 218 | 52.6 | 38.5 | 72.0 | 20.7 | 43.0 | 118 | 930 | 100% | 0.460 µg/L | ● |
| MEP | Diethyl phthalate (DEP) | Creatinine | µg/g creatinine | 218 | 57.5 | 44.3 | 74.6 | 23.9 | 46.2 | 120 | 534 | 100% | 0.460 µg/L | ● |
| MIBP | Di-isobutyl phthalate (DIBP) | NA | µg/L | 218 | 6.88 | 5.70 | 8.32 | 3.84 | 6.35 | 12.2 | 25.4 | 93.3% | 1.60 µg/L | ● |
| MIBP | Di-isobutyl phthalate (DIBP) | Creatinine | µg/g creatinine | 218 | 7.52 | 6.50 | 8.72 | 4.91 | 7.22 | 11.5 | 27.5 | 93.3% | 1.60 µg/L | ● |
| MnBP | Dibutyl phthalate (DBP), Benzylbutyl phthalate (BzBP) | NA | µg/L | 218 | 13.8 | 11.0 | 17.4 | 7.75 | 15.7 | 25.4 | 69.9 | 96.8% | 0.910 µg/L | ● |
| MnBP | Dibutyl phthalate (DBP), Benzylbutyl phthalate (BzBP) | Creatinine | µg/g creatinine | 218 | 15.1 | 12.9 | 17.7 | 8.67 | 15.4 | 22.5 | 51.8 | 96.8% | 0.910 µg/L | ● |
Footnotes
- ●Expanded BEST data from 218 participants was weighted, a statistical method to adjust over-represented and under-represented samples, so that the summary results adequately reflect the population of California’s Central Valley. Unweighted results are available to download on the Biomonitoring Exposures Study (BEST) – 2. Expanded project page.
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
Chemical Group: Polybrominated Diphenyl Ethers (PBDEs)
- Measured in: Serum
Weighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||||
| BDE 017 | BDE 17 | Lipids | ng/g lipid | 217 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.00770 ng/mL | ♦ * |
| BDE 028 | BDE 28 | Lipids | ng/g lipid | 217 | * | * | * | <LOD | <LOD | 2.61 | 5.04 | 47.4% | 0.00800 ng/mL | ♦ |
| BDE 047 | BDE 47 | Lipids | ng/g lipid | 217 | 20.8 | 17.2 | 25.2 | 9.64 | 22.0 | 42.8 | 108 | 99.2% | 0.0165 ng/mL | ♦ |
| BDE 066 | BDE 66 | Lipids | ng/g lipid | 217 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.6% | 0.00800 ng/mL | ♦ |
| BDE 085 | BDE 85 | Lipids | ng/g lipid | 217 | * | * | * | <LOD | <LOD | <LOD | 1.94 | 9.7% | 0.00800 ng/mL | ♦ |
| BDE 099 | BDE 99 | Lipids | ng/g lipid | 217 | 4.35 | 3.57 | 5.3 | 2.06 | 3.97 | 9.65 | 22.6 | 88.1% | 0.00898 ng/mL | ♦ |
| BDE 100 | BDE 100 | Lipids | ng/g lipid | 217 | 4.21 | 3.44 | 5.14 | 1.67 | 4.18 | 9.14 | 23.6 | 84.9% | 0.00800 ng/mL | ♦ |
| BDE 153 | BDE 153 | Lipids | ng/g lipid | 217 | 11.3 | 9.29 | 13.7 | 6.43 | 10.0 | 16.8 | 83.0 | 94.6% | 0.0160 ng/mL | ♦ |
| BDE 154 | BDE 154 | Lipids | ng/g lipid | 217 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.3% | 0.0160 ng/mL | ♦ |
| BDE 183 | BDE 183 | Lipids | ng/g lipid | 217 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.9% | 0.0160 ng/mL | ♦ |
| BDE 196 | BDE 196 | Lipids | ng/g lipid | 217 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.3% | 0.0160 ng/mL | ♦ |
| BDE 197 | BDE 197 | Lipids | ng/g lipid | 217 | * | * | * | <LOD | <LOD | <LOD | 3.53 | 7.4% | 0.0160 ng/mL | ♦ |
| BDE 201 | BDE 201 | Lipids | ng/g lipid | 217 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.3% | 0.0160 ng/mL | ♦ |
| BDE 202 | BDE 202 | Lipids | ng/g lipid | 217 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.3% | 0.0160 ng/mL | ♦ |
| BDE 203 | BDE 203 | Lipids | ng/g lipid | 217 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.3% | 0.0160 ng/mL | ♦ |
| BDE 206 | BDE 206 | Lipids | ng/g lipid | 217 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.4% | 0.0200 ng/mL | ♦ |
| BDE 207 | BDE 207 | Lipids | ng/g lipid | 217 | * | * | * | <LOD | <LOD | <LOD | <LOD | 3.9% | 0.0200 ng/mL | ♦ |
| BDE 208 | BDE 208 | Lipids | ng/g lipid | 217 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.4% | 0.0200 ng/mL | ♦ |
| BDE 209 | BDE 209 | Lipids | ng/g lipid | 190 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.4% | 0.257 ng/mL | ♦ |
Footnotes
- ♦Expanded BEST data from 217 participants was weighted, a statistical method to adjust over-represented and under-represented samples, so that the summary results adequately reflect the population of California’s Central Valley. Unweighted results are available to download on the Biomonitoring Exposures Study (BEST) – 2. Expanded project page.
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
Chemical Group: Polychlorinated Biphenyls (PCBs)
- Measured in: Serum
Weighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||||
| PCB 066 | PCB 066 | Lipids | ng/g lipid | 217 | * | * | * | <LOD | <LOD | <LOD | 1.94 | 9.7% | 0.00800 ng/mL | ♦ |
| PCB 074 | PCB 074 | Lipids | ng/g lipid | 217 | * | * | * | <LOD | <LOD | 4.27 | 11.6 | 47.1% | 0.00800 ng/mL | ♦ |
| PCB 099 | PCB 099 | Lipids | ng/g lipid | 217 | * | * | * | <LOD | 1.61 | 3.10 | 8.05 | 58.0% | 0.00800 ng/mL | ♦ |
| PCB 101 | PCB 101 | Lipids | ng/g lipid | 217 | * | * | * | <LOD | <LOD | <LOD | <LOD | 3.5% | 0.00800 ng/mL | ♦ |
| PCB 105 | PCB 105 | Lipids | ng/g lipid | 217 | * | * | * | <LOD | <LOD | <LOD | 3.47 | 18.9% | 0.00800 ng/mL | ♦ |
| PCB 118 | PCB 118 | Lipids | ng/g lipid | 217 | 2.85 | 2.34 | 3.46 | 1.29 | 2.52 | 4.78 | 13.4 | 77.5% | 0.00800 ng/mL | ♦ |
| PCB 138 | PCB 138 | Lipids | ng/g lipid | 217 | 5.11 | 4.08 | 6.39 | 2.32 | 4.32 | 10.6 | 25.6 | 93.1% | 0.00800 ng/mL | ♦ |
| PCB 153 | PCB 153 | Lipids | ng/g lipid | 217 | 10.1 | 7.88 | 12.8 | 4.00 | 9.18 | 26.2 | 56.5 | 99.7% | 0.00800 ng/mL | ♦ |
| PCB 156 | PCB 156 | Lipids | ng/g lipid | 217 | * | * | * | <LOD | 1.53 | 3.45 | 7.94 | 52.6% | 0.00800 ng/mL | ♦ |
| PCB 170 | PCB 170 | Lipids | ng/g lipid | 217 | 3.49 | 2.82 | 4.32 | <LOD | 3.50 | 8.88 | 16.1 | 71.7% | 0.00800 ng/mL | ♦ |
| PCB 180 | PCB 180 | Lipids | ng/g lipid | 217 | 9.42 | 7.26 | 12.2 | 3.07 | 9.40 | 29.3 | 54.0 | 97.7% | 0.00800 ng/mL | ♦ |
| PCB 183 | PCB 183 | Lipids | ng/g lipid | 217 | * | * | * | <LOD | <LOD | 2.67 | 5.13 | 43.7% | 0.00800 ng/mL | ♦ |
| PCB 187 | PCB 187 | Lipids | ng/g lipid | 217 | 3.14 | 2.55 | 3.88 | <LOD | 2.96 | 8.63 | 16.3 | 69.4% | 0.00800 ng/mL | ♦ |
| PCB 194 | PCB 194 | Lipids | ng/g lipid | 217 | * | * | * | <LOD | 2.08 | 5.33 | 11.9 | 58.8% | 0.00800 ng/mL | ♦ |
| PCB 203 | PCB 203 | Lipids | ng/g lipid | 217 | * | * | * | <LOD | 2.33 | 5.57 | 11.5 | 61.5% | 0.00800 ng/mL | ♦ |
Footnotes
- ♦Expanded BEST data from 217 participants was weighted, a statistical method to adjust over-represented and under-represented samples, so that the summary results adequately reflect the population of California’s Central Valley. Unweighted results are available to download on the Biomonitoring Exposures Study (BEST) – 2. Expanded project page.
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
Chemical Group: Polycyclic Aromatic Hydrocarbons (PAHs)
- Measured in: Urine
Weighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||||
| 1-NAP | Naphthalene | NA | pg/mL | 218 | 1,230 | 873 | 1,730 | 569 | 1,060 | 2,740 | 14,700 | 98.4% | 25 pg/mL | ● |
| 1-NAP | Naphthalene | Creatinine | ng/g creatinine | 218 | 1,340 | 983 | 1,840 | 567 | 948 | 2,530 | 18,100 | 98.4% | 25 pg/mL | ● |
| 1-PHEN | Phenanthrene | NA | pg/mL | 218 | 104 | 84.4 | 129 | 69.9 | 106 | 179 | 521 | 97.9% | 10 pg/mL | ● |
| 1-PHEN | Phenanthrene | Creatinine | ng/g creatinine | 218 | 114 | 95.6 | 136 | 64.4 | 107 | 164 | 427 | 97.9% | 10 pg/mL | ● |
| 1-PYR | Pyrene | NA | pg/mL | 218 | 105 | 83.0 | 134 | 56.8 | 102 | 205 | 497 | 90.5% | 20 pg/mL | ● |
| 1-PYR | Pyrene | Creatinine | ng/g creatinine | 218 | 115 | 93.9 | 141 | 62.6 | 104 | 151 | 909 | 90.5% | 20 pg/mL | ● |
| 2-FLUO | Fluorene | NA | pg/mL | 218 | 201 | 164 | 245 | 118 | 209 | 325 | 922 | 98.4% | 20 pg/mL | ● |
| 2-FLUO | Fluorene | Creatinine | ng/g creatinine | 218 | 219 | 185 | 260 | 127 | 178 | 299 | 1,160 | 98.4% | 20 pg/mL | ● |
| 2-NAP | Naphthalene | NA | pg/mL | 218 | 3,640 | 2,990 | 4,420 | 1,780 | 3,490 | 7,940 | 19,500 | 100% | 20 pg/mL | ● |
| 2-NAP | Naphthalene | Creatinine | ng/g creatinine | 218 | 3,980 | 3,330 | 4,750 | 1,920 | 3,740 | 6,820 | 19,900 | 100% | 20 pg/mL | ● |
| 2-PHEN | Phenanthrene | NA | pg/mL | 218 | 35.0 | 29.0 | 42.1 | 21.1 | 39.0 | 55.7 | 164 | 91.2% | 10 pg/mL | ● |
| 2-PHEN | Phenanthrene | Creatinine | ng/g creatinine | 218 | 38.2 | 32.5 | 44.9 | 24.3 | 34.5 | 54.6 | 134 | 91.2% | 10 pg/mL | ● |
| 3-FLUO | Fluorene | NA | pg/mL | 218 | 96.3 | 74.1 | 125 | 43.9 | 90.4 | 163 | 1150 | 89.8% | 20 pg/mL | ● |
| 3-FLUO | Fluorene | Creatinine | ng/g creatinine | 218 | 105 | 83.4 | 133 | 53.2 | 82.8 | 148 | 1,140 | 89.8% | 20 pg/mL | ● |
| 3-PHEN | Phenanthrene | NA | pg/mL | 218 | 56.1 | 45.5 | 69.3 | 37.2 | 57.3 | 109 | 247 | 93.3% | 10 pg/mL | ● |
| 3-PHEN | Phenanthrene | Creatinine | ng/g creatinine | 218 | 61.4 | 51.3 | 73.4 | 34.5 | 56.2 | 78.3 | 468 | 93.3% | 10 pg/mL | ● |
| 9-FLUO | Fluorene | NA | pg/mL | 218 | 274 | 217 | 344 | 143 | 271 | 507 | 2140 | 96.3% | 37 pg/mL | ● |
| 9-FLUO | Fluorene | Creatinine | ng/g creatinine | 218 | 299 | 246 | 363 | 156 | 266 | 478 | 1,890 | 96.3% | 37 pg/mL | ● |
Footnotes
- ●Expanded BEST data from 218 participants was weighted, a statistical method to adjust over-represented and under-represented samples, so that the summary results adequately reflect the population of California’s Central Valley. Unweighted results are available to download on the Biomonitoring Exposures Study (BEST) – 2. Expanded project page.
Chemical Group: Pyrethroid Pesticides
- Measured in: Urine
Weighted Results
| Chemical measured | Indicates Exposure to | Adjusted for | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||||
| 3-Phenoxybenzoic acid (3-PBA) | Cyhalothrin, cypermethrin, deltamethrin, fenpropathrin, permethrin, and/or tralomethrin | NA | µg/L | 218 | 0.660 | 0.480 | 0.908 | 0.305 | 0.783 | 1.47 | 5.39 | 90.9% | 0.0500 µg/L | ● |
| 3-Phenoxybenzoic acid (3-PBA) | Cyhalothrin, cypermethrin, deltamethrin, fenpropathrin, permethrin, and/or tralomethrin | Creatinine | µg/g creatinine | 218 | 0.722 | 0.558 | 0.934 | 0.386 | 0.747 | 1.27 | 6.41 | 90.9% | 0.0500 µg/L | ● |
| 4-Fluoro-3-phenoxybenzoic acid (4F-3-PBA) | Cyfluthrin | NA | µg/L | 218 | * | * | * | <LOD | <LOD | <LOD | 0.224 | 19.7% | 0.0500 µg/L | ● |
| 4-Fluoro-3-phenoxybenzoic acid (4F-3-PBA) | Cyfluthrin | Creatinine | µg/g creatinine | 218 | * | * | * | <LOD | <LOD | <LOD | 0.230 | 19.7% | 0.0500 µg/L | ● |
| Trans-DCCA | Cyfluthrin, cypermethrin, permethrin | Creatinine | µg/g creatinine | 218 | 0.505 | 0.383 | 0.666 | 0.221 | 0.488 | 1.15 | 6.30 | 92.6% | 0.0500 µg/L | ● |
Footnotes
- ●Expanded BEST data from 218 participants was weighted, a statistical method to adjust over-represented and under-represented samples, so that the summary results adequately reflect the population of California’s Central Valley. Unweighted results are available to download on the Biomonitoring Exposures Study (BEST) – 2. Expanded project page.
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.